SSelectStock

NEPHROPLUSNephrocare Health Services Limited

Healthcare · Medical Care Facilities · NSE · as of 2026-10-26 (delayed ~30 min in market hours)

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.

₹607.40
▲ 1.84%
46Average

Mkt Cap
₹6,105 Cr
P/E
71.5
P/B
5.4
Div Yield
0.00%
52W High
₹781.50
52W Low
₹446.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)6,104.70
P/E71.54
P/B5.41
PEG0.28
ROE %6.90
ROCE %11.40
Debt / Equity0.07
EPS8.49
Revenue Growth %22.20
Profit Growth %296.20
Dividend Yield %0.00
Promoter Holding %49.30
FII Holding %37.09
DII Holding %—
Beta0.68

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

AVOIDConviction 61%

Why avoid

  • • A bearish pattern is active and overall evidence is mixed
  • • ROE: 6.9%
  • • Valuation vs sector: P/E 71.5 vs sector 45.7
  • • RSI: 32
  • • MACD: bearish
  • • Double Top bearish signal (setup quality 64%)

⚖️ 1 bullish pattern setup is currently active on this stock. Pattern setup-quality percentages measure how cleanly a chart formation developed — they are not an endorsement of the company. Short-term traders may still trade those setups with strict stops; the AVOID verdict reflects the overall risk/fundamental profile for holding.

Bull case

  • • Revenue growth: 22.2% YoY
  • • Profit growth: 296.2% YoY
  • • Debt/Equity: 0.07
  • • Golden cross setup: SMA50 above SMA200

Bear case

  • • ROE: 6.9%
  • • Valuation vs sector: P/E 71.5 vs sector 45.7
  • • RSI: 32
  • • MACD: bearish

Key risks

  • • Momentum is fading versus the broader market
  • • ROE: 6.9%
  • • Valuation vs sector: P/E 71.5 vs sector 45.7

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹607.40
Stop Loss
₹574.40
risk 5.4%
Target 1 (1.5R)
₹656.90
+8.1%
Target 2 (3R)
₹706.41
+16.3%
Support (20d)
₹580.20
Resistance (52w)
₹781.50
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹33.00/share
ATR (volatility)
₹19.34
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹19.34). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental64
Technical31
Momentum28
Risk (safety)72

Peers — Healthcare

INDGN▲ 5.22%
68
SAGILITY▲ 0.72%
65
MOMSBELIEF▼ 4.32%
65
DRAGARWQ▲ 2.23%
61
LALPATHLAB▲ 0.95%
60
GKSL▲ 0.63%
58